Device Pain Management

Coolief* Cooled Radiofrequency

Payments companies reported to CMS as associated with Coolief* Cooled Radiofrequency. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$472Kassociated payments (2023-2025)
508clinicians with associated payments
1company reporting

By year

2023 $15K
2024 $457K

Payments reported as associated with Coolief* Cooled Radiofrequency, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine $109K
Interventional Pain Medicine $104K
Diagnostic Radiology $86K
Anesthesiology $55K
Physical Medicine & Rehabilitation $37K
Pain Medicine (Anesthesiology) $35K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Coolief* Cooled Radiofrequency

These are the largest totals companies reported as associated with Coolief* Cooled Radiofrequency. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Felix Gonzalez Atlanta, GA Diagnostic Radiology $55,815.23
Rajiv Tewari Fishers, IN Pain Medicine $45,443.63
Maxim Eckmann San Antonio, TX Anesthesiology $42,763.19
Sandeep Amin Chicago, IL Interventional Pain Medicine $39,876.44
Alaa Abd-Elsayed Madison, WI Pain Medicine $36,856.72
Chad Stephens Southlake, TX Interventional Pain Medicine $36,712.39
Zachary Mccormick Chicago, IL Physical Medicine & Rehabilitation $34,259.59
Antonia Chen Dallas, TX Adult Reconstructive Orthopaedic Surgery $26,696.44
Sean Li Shrewsbury, NJ Pain Medicine (Anesthesiology) $23,682.33
John Smirniotopoulos New York, NY Diagnostic Radiology $20,110.94

Prescribed Coolief* Cooled Radiofrequency?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.